New scanner aims to cut repeat breast cancer surgeries

NCT ID NCT07341542

Not yet recruiting Diagnosis Sponsor: Silesian Hospital in Opava Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study will test a device called the Histolog Scanner in 20 women having breast-conserving surgery for breast cancer. The scanner uses special microscopy to check if all cancer has been removed while the patient is still in the operating room. The goal is to see if this can reduce the number of women who need a second surgery because cancer cells were left behind. The study is observational and does not change standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Histolog scanner (device)
What this could lead to: If successful, this scanner could help surgeons remove all cancer in one operation, reducing the need for a second surgery.
What could go wrong: This is a very small pilot study with only 20 patients, so results may not apply to everyone. The scanner is still experimental and not yet proven to reduce reoperations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Margins of Excision

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Silesian Hospital in Opava

Opava, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.